Intestinal flora metabolism modulation

Intestinal flora metabolism modulation" describes the process of deliberately altering the composition and/or metabolic activity of the gut microbiota to impact host physiological or pathological states. Therapeutic strategies include the use of **prebiotics**, **probiotics**, **synbiotics**, **antibiotics**, and **fecal microbiota transplantation** to influence microbial populations or their metabolic products, such as short-chain fatty acids, bile acids, and other metabolites relevant to host metabolism, immunity, and disease risk[2][4][5][6]. This approach is being explored primarily in the context of metabolic diseases (e.g., obesity, type 2 diabetes), colorectal cancer, and other gut-related disorders, with mechanisms involving changes to microbial ecology, metabolic output, immune modulation, and gut barrier integrity[4][6]. However, the field lacks standardized molecular targets, and interventions generally work at the community or ecosystem level rather than on a defined molecular entity such as a receptor, transporter, or enzyme[2][6]. As such, "intestinal flora metabolism modulation" is not itself a molecule or target but an area of therapeutic modulation with broad application, significant interest, and outstanding questions regarding safety and efficacy[6].

Other names

Gut microbiota modulationGut flora metabolic modulationModulation of gut microbiome metabolismMicrobiota modulation

Alteration of microbial composition, stimulation/inhibition of bacteria, manipulation of microbial metabolites, restoration of microbial diversity, and immune system modulation.